Sign in
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022
Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Ranibizumab for Radiation Retinopathy (RRR) A Prospective, Multicenter Trial of Monthly Versus PRN Dosing for Radiation Retinopathy-Related Macular Edema
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2018
Category: AMD-Neovascular